Sertraline treatment influences [ 18 F]FE-PE2I PET imaging for Parkinsonism.

Thomas E H JustesenPer BorghammerJoel AanerudPeter HovindLisbeth Marner

Published in: EJNMMI research (2023)

F]FE-PE2I PET especially in patients showing apparent globally reduced PE2I binding. If tolerable, pausing of the sertraline treatment should be considered, especially for doses above 50 mg/day.

Keyphrases

pet imaging
end stage renal disease
chronic kidney disease
ejection fraction
computed tomography
prognostic factors
positron emission tomography
magnetic resonance
patient reported outcomes
aqueous solution
binding protein
smoking cessation